Cargando…
MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo
The human persistent and oncogenic Epstein-Barr virus (EBV) was one of the first viruses that were described to express viral microRNAs (miRNAs). These have been proposed to modulate many host and viral functions, but their predominant role in vivo has remained unclear. We compared recombinant EBVs...
Autores principales: | Murer, Anita, Rühl, Julia, Zbinden, Andrea, Capaul, Riccarda, Hammerschmidt, Wolfgang, Chijioke, Obinna, Münz, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336420/ https://www.ncbi.nlm.nih.gov/pubmed/30647153 http://dx.doi.org/10.1128/mBio.01941-18 |
Ejemplares similares
-
Erratum for Murer et al., “MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo”
por: Murer, Anita, et al.
Publicado: (2019) -
EBV persistence without its EBNA3A and 3C oncogenes in vivo
por: Murer, Anita, et al.
Publicado: (2018) -
NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
por: Chijioke, Obinna, et al.
Publicado: (2016) -
CD8(+) T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo
por: Chatterjee, Bithi, et al.
Publicado: (2019) -
Vaccination against the Epstein–Barr virus
por: Rühl, Julia, et al.
Publicado: (2020)